AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Moovila-AQ Injection

Prescription Icon
Prescription Required

Marketer

Evitalife Pharma Private Limited

Salt Composition

Diclofenac (75mg)

Overview Moovila-AQ Injection

Aquesol injection provides analgesia. Indicated for pain, inflammation, and stiffness associated with rheumatoid arthritis, osteoarthritis, and acute musculoskeletal trauma, it's administered parenterally when oral intake is infeasible. Injection must be given by a qualified healthcare provider; self-administration is strictly prohibited. Pre-existing cardiac or cerebrovascular disease should be disclosed to your physician. Report any injection site reactions (pain, swelling, erythema) immediately. Common adverse effects include nausea, emesis, cephalgia, and local injection site responses. Prolonged therapy may necessitate regular monitoring of renal and hepatic function, and hematologic parameters. Chronic use carries a risk of serious complications including gastrointestinal hemorrhage and nephropathy.

Uses of Moovila-AQ Injection

Alleviation of discomfort

Major Benefits of Moovila-AQ Injection:

Administering this medication will be handled by your physician or their designated nurse; self-medication is strictly prohibited.

Common Side effects of Moovila-AQ Injection:

  • Injection site reactions (pain, swelling, redness)
  • Vomiting
  • Flatulence
  • Edema (swelling)
  • Nausea
  • Headache
  • Dizziness

How to use Moovila-AQ Injection:

This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.

How Moovila-AQ Injection works:

Moovila-AQ Injection is a non-steroidal anti-inflammatory drug (NSAID) that inhibits the production of inflammatory mediators responsible for pain and associated swelling and redness.

SAFETY ADVICE

AlcoholAlcoholCAUTION

Exercise caution when using Moovila-AQ Injection concurrently with alcohol. Physician consultation is recommended.

PregnancyPregnancyCONSULT YOUR DOCTOR

Administering Moovila-AQ Injection during pregnancy is contraindicated due to established risks to fetal development. Nevertheless, in exceptional life-threatening circumstances, a physician might deem its use justifiable if the potential benefits outweigh the known hazards. Physician consultation is essential.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Moovila-AQ Injection while breastfeeding is likely inadvisable. Available human data indicates a potential for the medication to transfer to breast milk, posing a risk to the infant.

DrivingDrivingUNSAFE

Administration of Moovila-AQ Injection may impair driving ability due to potential adverse effects.

KidneyKidneyCAUTION

Patients with kidney impairment should use Moovila-AQ Injection cautiously; dose modification may be necessary. Physician consultation is advised.

LiverLiverCAUTION

Patients with liver impairment should use Moovila-AQ Injection judiciously, potentially requiring dose modification. Physician consultation is recommended.

What if you forget to take Moovila-AQ Injection :

Omit a Moovila-AQ Injection dose? Seek your physician's advice.

Facts to Know About Moovila-AQ Injection

LabelValue
Chemical Category Phenylacetic Acid Analog
Developing Habits No.
Type of Treatment Pain Relievers

FAQs on Moovila-AQ Injection

Moovila-AQ Injection must be administered only by a healthcare professional. It can be injected intramuscularly (preferably in the buttock), subcutaneously, or intravenously as a bolus, but never as an infusion. The prescribed dose must not be exceeded, and treatment should not last longer than two days.
Moovila-AQ Injection may increase your risk of heart attack or stroke, particularly with higher doses or prolonged use. It can also cause stomach and intestinal ulcers, bleeding, or perforation, potentially life-threatening and occurring without warning at any time. Seek immediate medical attention if you experience such symptoms.
Moovila-AQ Injection provides effective pain and inflammation relief. Its applications include sprains, strains, other injuries, various arthritic conditions, gout, and post-surgical pain and inflammation.
Moovila-AQ Injection, when used long-term or in high doses, can lead to renal issues like proteinuria, hematuria, and dysuria. Individuals at heightened risk of kidney problems—including those who are dehydrated, have heart failure, impaired renal function, hypertension, are elderly, or take diuretics or other nephrotoxic medications—should undergo kidney function monitoring.
Moovila-AQ Injection may cause drowsiness, dizziness, fatigue, and visual disturbances, though these side effects are uncommon. If you experience any of these, refrain from driving or operating machinery.
Avoid Moovila-AQ Injection during pregnancy, especially the last trimester, due to potential harm to the baby and the risk of premature labor. Its use should also be avoided during the first six months. Prescription during pregnancy should only occur when the potential benefits clearly outweigh the risks. Always consult your doctor before using Moovila-AQ Injection if you are pregnant.
Moovila-AQ Injection is not intoxicating and does not present a risk of abuse or dependence. If you experience any adverse effects, seek medical advice.
Moovila-AQ Injection is not a narcotic; it's a non-steroidal anti-inflammatory drug (NSAID).
Moovila-AQ Injection
13
MRP 15
13% off